Assessment of adverse events in patients switching between trastuzumab administration routes (subcutaneous to intravenous and intravenous to subcutaneous) in the PrefHer study

Affiliation auteurs!!!! Error affiliation !!!!
TitreAssessment of adverse events in patients switching between trastuzumab administration routes (subcutaneous to intravenous and intravenous to subcutaneous) in the PrefHer study
Type de publicationJournal Article
Year of Publication2014
AuteursGligorov J., Curigliano G., Mueller V., Knoop A., Jenkins V., Osborne S., Bazan S.PGil, Fallowfield L., Pivot X.
JournalEUROPEAN JOURNAL OF CANCER
Volume50
PaginationS45-S46
Date PublishedMAR
Type of ArticleMeeting Abstract
ISSN0959-8049